KG

Ketaki Ganesh Vaidya

Active Director Director DIN 11026438
DIN 11026438 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value •••• Premium profile

About Ketaki Ganesh Vaidya

Data last updated:

Ketaki Ganesh Vaidya is a Director at S Kant Healthcare Limited (since 2025). The company operates in Pharma. S Kant Healthcare Limited reported revenue of ₹452 Cr (FY 2025).

DIN 11026438
Primary Designation Director
Industry Pharma
First Appointment 29 Mar 2025
Oldest Company Age 30 yrs
Largest company S Kant Healthcare Limited · ₹452 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
S Kant Healthcare Limited U24230MH1996PLC098246
Director29 Mar 20251996₹452 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
S Kant Healthcare Limited
Premium access

Shareholding and investment profile for Ketaki Ganesh Vaidya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ketaki Ganesh Vaidya

Ketaki Ganesh Vaidya currently holds 1 directorship: S Kant Healthcare Limited (Director, since 29 Mar 2025, revenue ₹452 Cr (FY 2025)).

Ketaki Ganesh Vaidya was first appointed on 29 Mar 2025 as Director at S Kant Healthcare Limited.

The current boards of Ketaki Ganesh Vaidya's companies include Bharat Nemchand Shah (S Kant Healthcare Limited), Gaurav Satish Shah (S Kant Healthcare Limited), Mahesh Harishchandra Kolambe (S Kant Healthcare Limited), Ritesh Bipin Shah (S Kant Healthcare Limited), Rohan Mahesh Shah (S Kant Healthcare Limited), Samir Jayantilal Shah (S Kant Healthcare Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available